Antibodies to human T lymphotropic virus type III demonstrated by a dot immunobinding assay. 1985

G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo

A dot immunobinding (DIB) technique was applied to the demonstration of antibodies to human T-lymphotropic virus type III (HTLV-III). By this technique IgG antibodies to HTLV-III were demonstrated in six of six Swedish patients with acquired immune deficiency syndrome and in 37 of 39 (95%) Swedish homosexual men with persistent generalized lymphadenopathy but in none of 50 Swedish healthy blood donors. Findings obtained by this method showed complete concordance with those obtained by an enzyme-linked immunosorbent assay. All sera positive by DIB were also positive by Western blotting. The DIB assay is simple and well suited for screening of sera for HTLV-III antibodies.

UI MeSH Term Description Entries
D007158 Immunologic Techniques Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies. Antibody Dissociation,Immunologic Technic,Immunologic Technics,Immunologic Technique,Immunological Technics,Immunological Techniques,Technic, Immunologic,Technics, Immunologic,Technique, Immunologic,Techniques, Immunologic,Antibody Dissociations,Dissociation, Antibody,Dissociations, Antibody,Immunological Technic,Immunological Technique,Technic, Immunological,Technics, Immunological,Technique, Immunological,Techniques, Immunological
D008206 Lymphatic Diseases Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS. Lymphatism,Status Lymphaticus,Disease, Lymphatic,Diseases, Lymphatic,Lymphatic Disease
D008297 Male Males
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D017977 Deltaretrovirus A genus in the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B- or adult T-cell leukemia/lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), and bovine leukemia (ENZOOTIC BOVINE LEUKOSIS). The type species is LEUKEMIA VIRUS, BOVINE. BLV-HTLV Viruses,HTLV Viruses,HTLV-BLV Viruses,Human T-Cell Leukemia Viruses,Human T-Cell Leukemia-Lymphoma Viruses,Leukemia Viruses, Human T-Cell,T-Cell Leukemia Viruses, Human,Human T Cell Leukemia Lymphoma Viruses,Human T Cell Leukemia Viruses,Leukemia Viruses, Human T Cell,T Cell Leukemia Viruses, Human,BLV HTLV Viruses,HTLV BLV Viruses

Related Publications

G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo
June 1986, Journal of clinical microbiology,
G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo
January 1986, Hepatology (Baltimore, Md.),
G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo
January 1987, Hematologic pathology,
G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo
January 1987, Radiobiologia, radiotherapia,
G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo
January 1986, Vox sanguinis,
G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo
December 1985, The Japanese journal of experimental medicine,
G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo
December 1985, Annals of internal medicine,
G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo
January 2009, Methods in molecular biology (Clifton, N.J.),
G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo
January 1988, Avian diseases,
G Biberfeld, and U Bredberg-Råden, and B Böttiger, and P Biberfeld, and L Morfeldt-Månsson, and J Suni, and A Vaheri, and C Saxinger, and R Gallo
April 1986, Science (New York, N.Y.),
Copied contents to your clipboard!